[ad_1] There are questions that worry me profoundly as a population- and environmental-health scientist. Will…
development
-
-
STOCK MARKET
Apple reportedly pauses hiring for many roles, joining Amazon in belt-tightening
by userby user[ad_1] Apple Inc. reportedly has put a pause on hiring for positions that aren’t in…
-
[ad_1] BOSTON (Project Syndicate)—China highlights a long-debated question about economic development: Can a top-down autocracy…
-
[ad_1] Rents in Boston are soaring past housing costs in famously pricey California cities like…
-
[ad_1] Novartis AG NOVN, +0.47% NVS, +2.05% said Monday that a study on a drug…
-
STOCK MARKET
Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
by userby user[ad_1] A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and…
-
STOCK MARKET
‘There’s no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used?
by userby user[ad_1] A pair of new drugs offer something many Americans desperately want: a way to…
-
STOCK MARKET
Hurricane Ian devastated your home — here’s the important first steps for disaster relief and insurance claims
by userby user[ad_1] The full financial and human price of Hurricane Ian’s destruction is still unknown, days…
-
STOCK MARKET
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
by userby user[ad_1] Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker…
-
[ad_1] Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug significantly slowed progression of…